23 hours ago | ScienceDaily | 2 articles
Early results from a new, pioneering chimeric antigen receptor T cell immunotherapy trial found using a bilateral attack achieves a more robust defense and helps avoid relapse.
Read more ...
2 days ago | MedPageToday
Adding the PI3K inhibitor copanlisib to rituximab reduced the risk of disease progression or death for patients with relapsed indolent non-Hodgkin's lymphoma , including those...
Read more ...
3 days ago | MedPageToday
Substituting a targeted agent for a chemotherapy drug improved tolerance of an established therapy for high-risk pediatric Hodgkin lymphoma and allowed a third of patients to...
Read more ...
4 days ago | News Medical | 2 articles
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition...
Read more ...
5 days ago | News Medical
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma.
Read more ...
11 days ago | Healio
A 70-year-old man presented to the New England Eye Center with 1 day of blurry vision in the right eye, as well as a feeling of dryness and slight discomfort. He reported a...
Read more ...
13 days ago | Mamavation
Have you ever wondered how much glyphosate was in Honeymaid Graham Crackers? Well, one of our community members asked us to test them, so we did! Stick around for the results...
Read more ...
14 days ago | Medscape
The panel recommends EU approval for duvelisib for certain patients with chronic lymphocytic leukemia or follicular lymphoma.
International Approvals
Read more ...
18 days ago | News Medical | 2 articles
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas.
Read more ...
18 days ago | MedPageToday
In this video courtesy of VJHemOnc, Jonathon B. Cohen, MD, MS, co-director of the lymphoma program and medical director of infusion services at Winship Cancer Institute of...
Read more ...
Register you to post on Health Mag
Free Registration
Note that some links may require registration or subscription. The CDC and FDA confirm: six cases of cerebral venous sinus thrombosis with thrombocytopenia have occurred with... Read more ...
A good portion of superannuation fund members who dipped into their super last year would be left with a significant shortfall in retirement savings when they stop work. Read more ...
Albumedix Ltd. , a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the... Read more ...
The time children and adolescents spend on screen time entertainment -computers, mobile phones, television and video games- adversely affects their eating habits. Read more ...
From optogenetics to sonogenetics to magnetognetics, scientists around the world are investigating new techniques to treat Parkinson's disease without the need for invasive... Read more ...
With summer around the corner, a project shows how implementing an evidence-based mindfulness program in a summer camp setting decreases emotional distress in school age... Read more ...
A personalized cancer vaccine raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of... Read more ...
Researchers showed that a new hyaluronic acid hydrogel system can reinforce and seal areas of injured cartilage in animal studies, paving the way for future fixes and healing. Read more ...
Memory B cells that bind to SARS-CoV-2 and cross-react with other coronaviruses were identified in kids even before the COVID-19 pandemic. Read more ...
People who have recovered from COVID-19, especially those with pre-existing cardiovascular conditions, may be at risk of developing blood clots due to a lingering and... Read more ...